7 Aug 2026, 11:24 UTC10 views3 reactionsread 10 August 2026 🔮 Prediction Markets are now live on Fintch
You can now trade on macro and policy outcomes directly in the app - no IPO shares, just a straight view on what happens next.
Two markets are open today:
1. How many times will the Fed cut rates in 2026?
Resolves on the total number of 25bp cuts through the December FOMC meeting, including any inter-meeting emergency cuts (a 50bp cut counts as two). Right now the market…
⚡1🔥1🤝1
5 Aug 2026, 10:11 UTC11 views4 reactionsread 10 August 2026 Photo
🎗 New IPO: Latigo Biotherapeutics (#LTGO)
A new IPO is now available in the Fintch app.
Latigo Biotherapeutics is a Thousand Oaks, California clinical-stage biopharma founded in 2018 by Westlake Village BioPartners, developing non-opioid oral pain therapies targeting Nav1.8 - a peripheral sodium channel genetically and clinically linked to pain signaling. CEO Nima Farzan (ex-Kinnate Biopharma, PaxVax, Novartis - le…
👍2👌1🔥1
5 Aug 2026, 07:34 UTC9 views4 reactionsread 10 August 2026 Photo
🎯 New IPO: BlossomHill Therapeutics (#BLSM)
A new IPO is now available in the Fintch app.
BlossomHill Therapeutics is a San Diego clinical-stage biopharma founded in 2020, developing targeted small-molecule oncology drugs using structure-based design and macrocyclic chemistry to overcome drug resistance. Founder, President and CEO Dr. J. Jean Cui - lead developer of three FDA-approved drugs (Xalkori, Lorbrena, Augt…
🔥2👌1🙏1
4 Aug 2026, 06:59 UTC11 views4 reactionsread 10 August 2026 Photo
❤️ New IPO: Braveheart Bio (#BRVE)
A new IPO is now available in the Fintch app.
Braveheart Bio is a San Francisco clinical-stage biopharma, founded just 8 months ago (November 2025), developing treatments for hypertrophic cardiomyopathy (HCM). Lead asset BHB-1893 is a next-generation oral cardiac myosin inhibitor for both obstructive (oHCM) and non-obstructive (nHCM) forms. Chairman Chris Viehbacher, former CEO of…
🔥2👍1👏1
3 Aug 2026, 07:05 UTC11 views3 reactionsread 10 August 2026 Photo
🧬 New IPO: Attovia Therapeutics (#ATTO)
A new IPO is now available in the Fintch app.
Attovia Therapeutics is a San Carlos, California clinical-stage biopharma founded in 2022-2023, developing next-generation biologics for immune-mediated diseases on its proprietary ATTOBODY platform. CEO Tao Fu. CMO Dr. Hubert Chen, formerly SVP of Clinical Development at Krystal Biotech. Backed by Goldman Sachs Alternatives, Deep…
👍1👏1🔥1
29 Jul 2026, 07:00 UTC15 views4 reactionsread 10 August 2026 Photo
😴 New IPO: Apnimed (#APMD)
A new IPO is now available in the Fintch app.
Apnimed is a Cambridge, Massachusetts late-stage clinical biopharma founded in 2017, developing the world's first pill for obstructive sleep apnea (OSA). Single lead candidate: AD109 (brand name Oxnimbi), a once-daily oral tablet taken at bedtime. This is one of the most de-risked biotech IPOs of the year - two Phase 3 trials completed, NDA su…
❤2👍1🔥1
23 Jul 2026, 08:13 UTC14 views4 reactionsread 10 August 2026 Photo
🥪 New IPO: Jersey Mike's Subs (#JMKE)
A new IPO is now available in the Fintch app.
Jersey Mike's is the second-largest US submarine sandwich chain by systemwide sales after Subway, founded 1956, HQ in Tinton Falls, NJ. Pure franchise model: 99% of 3,300+ locations are independently owned. Blackstone acquired a controlling stake in January 2025 at an ~$8B valuation - the largest restaurant PE deal at this scale. CE…
🔥2👍1👏1
22 Jul 2026, 14:11 UTC13 views3 reactionsread 10 August 2026 Photo
👗 New IPO: Reformation (#REF)
A new IPO is now available in the Fintch app.
Reformation is a Vernon, California DTC apparel company founded in 2009, positioned as the world's largest sustainable womenswear brand. Dresses, denim, tops, shoes, handbags built around recycled materials and supply chain transparency. CEO since 2018 is Hali Borenstein (ex-Bain, former internal merchandising lead). Founder Yael Aflalo sta…
🔥3
22 Jul 2026, 07:10 UTC12 views6 reactionsread 10 August 2026 Photo
🧬 New IPO: Scribe Therapeutics (#SCTX)
A new IPO is now available in the Fintch app.
Scribe Therapeutics is an Alameda, California clinical-stage biotech founded in 2017, developing purpose-built in vivo CRISPR technologies for common, broadly prevalent diseases - starting with cardiometabolic disorders. Co-founder and CSO Dr. Jennifer Doudna, 2020 Nobel Laureate in Chemistry and foundational discoverer of CRISPR-C…
👌2👍2❤1🔥1
13 Jul 2026, 06:15 UTC16 views5 reactionsread 10 August 2026 Photo
☢️ New IPO: Standard Nuclear (#STDN)
A new IPO is now available in the Fintch app.
The only independent US manufacturer of TRISO fuel – un-meltable, poppy-seed-sized nuclear fuel particles that next-gen reactors (Xe-100, Kairos, DOE MARVEL) are designed around. Founded 2025 out of bankrupt Ultra Safe Nuclear's assets, HQ Oak Ridge, TN. CEO Dr. Kurt Terrani, former nuclear fuel director at Oak Ridge National Lab. Re…
👍2🔥2👏1
9 Jul 2026, 11:15 UTC19 views5 reactionsread 10 August 2026 Photo
🏢 New IPO: Csquare (#CSQR)
A new IPO is now available in the Fintch app.
Csquare is a North American carrier-neutral colocation and interconnection platform across the US, Canada, and the UK. Founded 2019, HQ in Texas. 64 data centers across 21 metros, ~389 MW of capacity, 1,700+ clients. CEO Spencer Mullee. Controlling shareholder: Brookfield Corporation (NYSE: BN), ~67.1% voting power – a "controlled company" und…
👏2🔥2🙏1
8 Jul 2026, 10:13 UTC21 views5 reactionsread 10 August 2026 Photo
🚀 Cards are here
Fintch now issues Visa and Mastercard - right in the app, no bank visit, no paperwork.
• Issuance from $12 - one of the cheapest entries on the market
• No KYC required
• Top up with stablecoins (USDT) - or a regular card
• Issued in minutes, fully inside the app
Two cards, two jobs:
💳 Singapore / Hong Kong Card
Pay for ChatGPT, Netflix and international subscriptions.
Cannot be added to Google P…
👍2👏2🎉1
Showing the 12 most recent of 20 posts we hold for @fintchone. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.